The results of our study indicated that CAD patients with LDL-C ≥ 100 mg/dL might suffer more from elevated Lp(a); by contrast, Lp(a) was not associated with all-cause mortality in patients whose LDL-C was well-controlled. This evidence concerns the gene LPA and coronary artery disorder.